Post-approval studies (Phase 4)Study completedNCT00191555
What this trial is testing
Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment
Who this might be right for
Schizophrenia
Eli Lilly and Company 360